Atlas Trials

Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

Clinical trial NCT03784755 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03784755
Sponsor
Canadian Cancer Trials Group
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer Metastatic
Start date
2019-11-15
Primary completion
2032-12-31
Enrollment
409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.